Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Pfizer Anti-Infectives AB

Closing information (x1000 SEK)

Closing information 2024/11 2023/11 2022/11
Turnover 1,826,423 More Arrow 2,115,306 Less Arrow 1,353,259
Financial expenses 0 Equal arrow 0 More Arrow 472
Earnings before taxes 1,083,763 Less Arrow 1,010,662 Less Arrow 415,181
EBITDA 1,018,428 More Arrow 1,042,889 Less Arrow 474,848
Total assets 2,878,110 Less Arrow 2,513,576 Less Arrow 1,580,650
Current assets 98,576 Less Arrow 66,595 More Arrow 112,359
Current liabilities 259,724 More Arrow 756,144 Less Arrow 625,691
Equity capital 2,618,386 Less Arrow 1,757,432 Less Arrow 954,959
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2024/11 2023/11 2022/11
Solvency 91.0% Less Arrow 69.9% Less Arrow 60.4%
Turnover per employee
Profit as a percentage of turnover 59.3% Less Arrow 47.8% Less Arrow 30.7%
Return on assets (ROA) 37.7% More Arrow 40.2% Less Arrow 26.3%
Current ratio 38.0% Less Arrow 8.8% More Arrow 18.0%
Return on equity (ROE) 41.4% More Arrow 57.5% Less Arrow 43.5%
Change turnover -288,883 More Arrow 762,047 More Arrow 1,022,736
Change turnover % -14% More Arrow 56% More Arrow 309%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/11 2023/11 2022/11
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.